Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research Addressing, addressed an audience at healthcare investment bank Leerink Swann’s Global Healthcare Conference last month, emphasizing the need for increased coordination of government, business, and academic efforts to improve pain prevention, care, education, and research by 2015.
The National Institutes of Health hopes to strengthen industry and foundation funding of abuse-resistant opioids and non-opioid pain drugs through public-private partnerships, which will be explored by the new Interagency Pain Research Coordinating Committee established under the PPACA. The committee, made up of researchers, advocates and federal agency members, held its inaugural meeting at the end of March.
Related Articles on Pain Management:
West Virginia Gov. Signs Bill to Curb “Doctor Shopping”
Opioids Increasingly Prescribed for Chronic Abdominal Pain, Study Says
Soldiers Need Greater Emphasis on Pain Management Treatment, Physician Says
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
